Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma

Journal of Urology

Volumn 159, Issue 1, 1998, Pages 245-251

  Kinoshita, Hidefumi ^a   Ogawa, Osamu ^a   Mitsumori, Kenji ^a   Kakehi, Yoshiyuki ^a   Terachi, Toshiro ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Chromophobe cell; Renal cell carcinoma; Telomerase; Telomere

Indexed keywords

TELOMERASE;

ARTICLE; CELL IMMORTALIZATION; CHROMOPHOBE ADENOMA; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TELOMERE;

EID: 0031986410     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64076-X     Document Type: Article

References (38)

1. Blackburn, E. H.: Structure and function of telomeres. Nature, 350: 569, 1991.
2. Watson, D. J.: Origin of concatameric T7 DNA. Nature New Biol., 239: 197, 1972.
3. Olovnikov, A. M.: A theory of marginotomy. J. Theoret. Biol., 41: 181, 1973.
4. Harley, C. B.: Telomere loss: mitotic clock or genetic time bomb? Mutat. Res., 256: 271, 1991.
5. Allshire, R. C., Dempster, M. and Hastie, N. D.: Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res., 17: 4611, 1989.
6. Harley, C. B., Futcher, A. B. and Greider, C. W.: Telomeres shorten during ageing of human fibroblasts. Nature, 345: 458, 1990.
7. Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K. and Allshire, R. C.: Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346: 866, 1990.
8. Morin, G. B.: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521, 1989.
9. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B. and Bacchetti, S.: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921, 1992.
10. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L. and Shay, J. W.: Specific association of human telomerase activity with immortal cells and cancer. Science, 266: 2011, 1994.
11. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A. and Shay, J. W.: Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst., 87: 895, 1995.
12. Langford, L. A., Piatyszek, M. A., Xu, R., Schold, S. C., Jr. and Shay, J. W.: Telomerase activity in human brain tumours. Lancet, 346: 1267, 1995.
13. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A. and Shay, J. W.: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249, 1995.
14. Kovacs, G., Fuzesi, L., Emanual, A. and Kung, H. F.: Cytogenetics of papillary renal cell tumors. Genes Chromosomes & Cancer, 3: 249, 1991.
15. Thoenes, W., Storkel, S. and Rumpelt, H. J.: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract., 181: 125, 1986.
16. Kovacs, G.: Molecular differential pathology of renal cell tumours. Histopathology, 22: 1, 1993.
17. Kovacs, A. and Kovacs, G.: Low chromosome number in chromophobe renal cell carcinomas. Genes Chrom. Cancer, 4: 267, 1992.
18. Schwerdtle, R. F., Storkel, S., Neuhaus, C., Brauch, H., Weidt, E., Brenner, W., Hohenfellner, R., Huber, C. and Decker, H-J.: Allelic Losses at Chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Cancer Res., 56: 2927, 1996.
19. Mehle, C., Ljungberg, B. and Roos, G.: Telomere shortening in renal cell carcinoma. Cancer Res., 54: 236, 1994.
20. Dahse, R., Fiedler, W., Ernst, G., Kosmehl, H., Schlichter, A., Schubert, J. and Claussen, U.: Changes in telomere lengths in renal cell carcinomas. Cell. Mol. Biol. Noisy., 42: 477, 1996.
21. Mehle, C., Piatyszek, M. A., Ljungberg, B., Shay, J. W. and Roos, G.: Telomerase activity in human renal cell carcinoma. Oncogene, 13: 161, 1996.
22. Murphy, W. M., Beckwith, J. B. and Farrow, G. M.: Tumors of the kidney, bladder, and related urinary structures. fascicles 11. In: Atlas of Tumor Pathology (3rd edition), edited by J. Rosai. Armed Forces Institute, Washington, D. C.: Armed Forces Institute of Pathology, pp. 92-135, 1994.
23. Hashimura, T., Tubbs, R. R., Connelly, R., Caulfield, M. J., Trindade, C. S., McMahon, J. T., Galetti, T. P., Edinger, M., Sandberg, A. A., Cin, P. D., Sait, S. J. and Pontes, J. E.: Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. Cancer Res., 49: 7064, 1989.
24. Hoehn, W. and Schroeder, F. H.: Renal cell carcinoma: two new cell lines and a serially transplantable nude mouse tumor (NC 65): preliminary report. Invest. Urol., 16: 106, 1978.
25. Goldrosen, M. H., Huben, R., Miller, G. A., Lewis, D. A., Ochi, H., Sandberg, A. A. and Pontes, J. E.: Characterization of a renal cell carcinoma cell line suitable as a target for immunological studies in vitro and in the nu/nu mouse. J. Urol., 134: 1271, 1985.
26. Habuchi, T., Kinoshita, H., Yamada, H., Kakehi, Y., Ogawa, O., Wu, W. J., Takahashi, R., Sugiyama, T. and Yoshida, O.: Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J. Natl. Cancer Inst., 86: 1331, 1994.
27. Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A. and Shay, J. W.: Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88: 116, 1996.
28. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W. and Matsuura, Y.: Telomerase activity in gastric cancer. Cancer Res., 55: 3258, 1995.
29. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E. and Shay, J. W.: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17:1, 1995.
30. Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R. R.: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14: 4240, 1995.
31. Holzmann, K., Blin, N., Welter, C., Zang, K. D., Seitz, G. and Henn, W.: Telomeric associations and loss of telomeric DNA repeats in renal tumor. Genes Chrom. Cancer, 6: 178, 1993.
32. Thoenes, W., Storkel, S., Rumpelt, H. J., Moll, R., Baum, H. P. and Werner, S.: Chromophobe cell renal carcinoma and its variants: a report on 32 cases. J. Pathol., 155: 277, 1988.
33. Crotty, T. B., Farrow, G. M. and Lieber, M. M.: Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J. Urol., 154: 964, 1995.
34. Hiyama, K., Ishioka, S., Shirotani, Y., Inai, K., Hiyama, E., Murakami, I., Isobe, T., Inamizu, T. and Yamakido, M.: Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene, 10: 937, 1995.
35. Ohmura, H., Tahara, H., Suzuki, M., Ide, T., Shimizu, M., Yoshida, M. A., Tahara, E., Shay, J. W., Barrett, J. C. and Oshimura, M.: Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn. J. Cancer Res., 86: 899, 1995.
36. Ogawa, O., Kakehi, Y., Ogawa, K., Koshiba, M., Sugiyama, T. and Yoshida, O.: Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res., 51: 949, 1991.
37. Kinoshita, H., Ogawa, O., Kakehi, Y., Mishina, M., Mitsumori, K., Itoh, N., Yamada, H., Terachi, T. and Yoshida, O.: Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J. Natl. Cancer Inst. (in press).
38. Morin, G. B.: Is telomerase a universal cancer target? J. Natl. Cancer Inst., 87: 859, 1995.